Table 1. Clinical characteristics
VariablePre N = 36Early Peri N = 16Late Peri N = 21Early Post N = 21Late Post N = 35P‐value
Age, years33 ± 749 ± 350 ± 455 ± 361 ± 4<0.001
Weight, kg66.1 ± 13.667.2 ± 9.366.9 ± 13.373.9 ± 13.270.5 ± 13.80.21
BMI, kg/mb24.1 ± 5.625.2 ± 3.024.1 ± 4.327.7 ± 5.026.5 ± 4.70.03
Trunk fat, %29 ± 933 ± 734 ± 839 ± 639 ± 6<0.001
Waist circumference, cm78 ± 882 ± 982 ± 1387 ± 1485 ± 100.02
WHR0.79 ± 0.060.80 ± 0.070.80 ± 0.060.81 ± 0.080.81 ± 0.050.59
SBP, mmHg108 ± 8115 ± 11116 ± 13118 ± 13121 ± 13<0.001
DBP, mmHg69 ± 774 ± 772 ± 874 ± 873 ± 90.12
HR, bpm65 ± 1062 ± 864 ± 1065 ± 664 ± 70.80
Total cholesterol, mg/dL153 ± 30164 ± 26168 ± 33185 ± 32194 ± 30<0.001
LDL cholesterol, mg/dL88 ± 2497 ± 29100 ± 31112 ± 30120 ± 29<0.001
HDL cholesterol, mg/dL48 ± 1150 ± 851 ± 849 ± 1352 ± 110.68
Triglycerides, mg/dLa80 (67–140)79 (58–99)83 (78–106)80 (67–140)97 (75–131)0.007
Fasted glucose, mg/dL84 ± 887 ± 781 ± 889 ± 1286 ± 90.03
Fasted insulin, μIU/mLa6.0 (3.8–10.3)4.0 (3.3–8.0)4.0 (3.0–8.5)7.0 (4.5–13.5)6.0 (4.0–12.0)0.27
FSH, μIU/mL5.4 ± 3.027.6 ± 35.367.8 ± 37.472.6 ± 27.483.0 ± 29.2<0.001
Estradiol, pg/mLa64.0 (40.5–92.0)54.0 (31.0–139.0)39.0 (10.0–118)11.0 (10.0–15.5)10.0 (10.0–13.5)<0.001
Estrone, ng/dLa46.5 (35.8–68.3)61.5 (37.0–89.3)42.0 (28.0–72.5)29.0 (23.0–39.5)25.0 (20.0–36.5)<0.001
Testosterone, ng/dLa30.0 (19.0–45.0)26.5 (17.0–35.8)20.0 (17.0–25.5)19.0 (17.0–29.0)17.0 (17.0–24.8)0.003
VO2peak, mL/kg/minb33.6 ± 7.128.1 ± 4.727.5 ± 5.424.5 ± 3.122.9 ± 3.8<0.001
LTPA, MET‐hr/wkc16.7 ± 11.817.4 ± 10.814.6 ± 11.815.3 ± 21.212.8 ± 13.80.86
Brachial FMD, %9.8 ± 2.37.5 ± 2.36.5 ± 2.05.6 ± 1.94.8 ± 1.9<0.001
  • Data are mean ± standard deviation unless otherwise stated. Pre, premenopausal; Peri, perimenopausal; Post, postmenopausal; BMI, body mass index; WHR, waist hip ratio; SBP, systolic blood pressure; DBP, diastolic blood pressure; HR, heart rate; LDL, low‐density lipoprotein; HDL, high‐density lipoprotein; FSH, follicle stimulating hormone; VO2 peak, peak aerobic power; LTPA, leisure time physical activity; FMD, flow‐mediated dilation.

  • a Data are median (interquartile range)

  • b Sample sizes of 116

  • c Sample sizes of 109.